OTS.at

Polpharma Strengthens Its Position in Central and Eastern Europe – Biofarm, the Leader of the Romanian Market, Joins the Group

Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and ...
OTS.at

EQS-News: REPLOID has acquired a stake in Alimentastic with the option to obtain majority control

Investment REPLOID has acquired a stake in Alimentastic with the option to obtain majority control 21.07.2026 / 09:15 CET/CEST The issuer is solely responsible for the content of this announcement.
ots

EQS-PVR: Kontron AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Kontron AG Kontron AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution 20.07.2026 / 19:30 CET/CEST Dissemination of a ...
OTS.at

EQS-News: RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 20 July 2026

Tender Offer RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 20 July 2026 21.07.2026 / 08:30 CET/CEST The issuer is solely responsible for the ...
OTS.at

EQS-News: EVN makes significant progress in implementing its battery storage strategy

Miscellaneous EVN makes significant progress in implementing its battery storage strategy 14.07.2026 / 16:06 CET/CEST The issuer is solely responsible for the content of this announcement.
OTS.at

EQS-News: REPLOID reports strong earnings growth from 2023 to 2025

Annual Results REPLOID reports strong earnings growth from 2023 to 2025 17.07.2026 / 09:15 CET/CEST The issuer is solely responsible for the content of this announcement.
OTS.at

Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich

Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together ...
OTS.at

Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy

Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration ...
OTS.at

The strategies of Austria’s super-rich

Porsche & Piëch, Mayr-Melnhof and Mateschitz, to name but a few: surprisingly little is known about the wealth structures of Austria’s richest families. Researchers in Linz have conducted a study ...
OTS.at

EQS-News: Kontron AG: The Executive Board and Supervisory Board recommend that shareholders do not accept the mandatory takeover offer from Ennoconn Corporation

The Executive Board and Supervisory Board recommend that shareholders do not accept the mandatory takeover offer from Ennoconn Corporation 08.07.2026 / 18:03 CET/CEST The issuer is solely responsible ...
OTS.at

EQS-News: Publication of a resolution of the Annual General Meeting pursuant to Section 119 Para 9 Austrian Stock Exchange Act in connection with Section 3 Para 1 …

EQS-News: AT&S Austria Technologie & Systemtechnik AG / Key word(s): AGM/EGM Publication of a resolution of the Annual ...
OTS.at

REPLOID research project 'Opti2Fly' receives funding from the German Federal Ministry for Research, Technology and Space

CET/CEST PRESS RELEASE REPLOID research project "Opti2Fly" receives funding from the German Federal Ministry for Research, Technology and Space • €850,000 in federal funding for a research project ...